Jump to content

Syncytiotrophoblast

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Barbara (WVS) (talk | contribs) at 11:26, 24 July 2016 (added Category:Human female endocrine system using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Syncytiotrophoblast
Primary chorionic villi. Diagrammatic.
Secondary chorionic villi. Diagrammatic.
Details
Carnegie stage5a
Days8
Identifiers
Latinsyncitiotrophoblastus
TEE6.0.1.1.4.0.2
FMA83040
Anatomical terminology

Syncytiotrophoblast (from the Greek 'syn'- "together"; 'cytio'- "of cells"; 'tropho'- "nutrition"; 'blast'- "bud") is the epithelial covering of the highly vascular embryonic placental villi, which invades the wall of the uterus to establish nutrient circulation between the embryo and the mother. It is a unique tissue in that it is a multi-nucleated, terminally differentiated syncytium, extending to 13 cm.

Function

It is the outer layer of the trophoblasts and actively invades the uterine wall, rupturing maternal capillaries and thus establishing an interface between maternal blood and embryonic extracellular fluid, facilitating passive exchange of material between the mother and the embryo.

The syncytial property is important since the mother's immune system includes white blood cells that are able to migrate into tissues by "squeezing" in between cells[citation needed]. If they were to reach the fetal side of the placenta many foreign proteins would be recognised, triggering an immune reaction. However the syncytium acts as a giant cell so there are no gaps for immune cells to migrate through[citation needed].

One way in which it accomplish this task is by suppressing the expression of immunity-related genes HLA-A and HLA-B, which are classically known to be expressed by all nucleated cells.[1] These genes normally express the MHC-I ligand that acts as a major binding mechanism for T-cells. By decreasing the translation of these gene products, the syncytiotrophoblast reduces the chances of an attack by the maternal immune system mediated by T-cells.[1] Contrastingly, the syncytiotrophoblast does express HLA-G, a ligand for an NK cell inhibitory receptor, which protects the villi against NK cell-mediated death.[2]

The syncytiotrophoblast secretes progesterone and leptin in addition to human chorionic gonadotropin (hCG) and human placental lactogen (HPL); hCG prevents degeneration of the corpus luteum. Progesterone serves to maintain the integrity of the uterine lining and, until the syncytiotrophoblast is mature enough to secrete enough progesterone to support pregnancy (in the fourth month of embryonic development), it is aided by the corpus luteum graviditatis.[3]

Formation

The syncytiotrophoblast lacks proliferative capacity and instead is maintained by fusion of underlying cytotrophoblast cells. This fusion is assisted by syncytin, a protein that was integrated into mammalian genomes from an endogenous retrovirus.[4]

Additional images

See also

References

  1. ^ a b Jay Iams; Creasy, Robert K.; Resnik, Robert; Robert Reznik (2004). Maternal-fetal medicine.
  2. ^ Lash, G, Robson, S, Bulmer, J. (2010). "Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua". Placenta 31 (S): 87–92.doi:10.1016/j.placenta.2009.12.022
  3. ^ Langman's Medical Embryology, 10th Edition. T.W. Sadler. p. 34
  4. ^ Mi, S (Feb 17, 2000). "Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis". Nature. 403 (6771): 785–789. doi:10.1038/35001608. PMID 10693809.

Tony M. Plant, Anthony J. Zeleznik: "Knobil and Neill's Physiology of Reproduction: Two-Volume Set" p 1790